CLINICAL_TRIALS
trial_result
· 2023-03-20
Clinical Trial Update: Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne [Phase 2]
Summary
Phase 2 study assessing the efficacy and safety of LYS006 in moderate to severe inflammatory acne has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Inflammatory Acne | Phase 2 | Status: COMPLETED | Results posted: 2023-03-20